Among sarcoma types, higher expression of IL-13Rα2 in malignant peripheral nerve sheath tumors has been reported, and a therapeutic approach targeting IL-13Rα2 showed suppression of tumor growth and elongation of survival time in a murine tumor model [54]. This evidence concerns the gene IL13RA2 and sarcoma.